HCW Biologics Inc. (HCWB) stock
HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)
Close on Nov 18, 2026Market cap $1.40MP/E –Yield –
HCW Biologics cash
Cash and short-term investments held at the end of each period.
HCW Biologics's cash was $741.32K at Jun 30, 2026. For fiscal 2025 it was $1.95M, down 58.2% from the year before. The highest annual figure on record is $36.71M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.95M | -58.2% |
| FY2024 | Dec 31, 2024 | $4.67M | +30.0% |
| FY2023 | Dec 31, 2023 | $3.60M | -88.8% |
| FY2022 | Dec 31, 2022 | $32.06M | -12.7% |
| FY2021 | Dec 31, 2021 | $36.71M | +334.2% |
| FY2020 | Dec 31, 2020 | $8.46M | +15.0% |
| FY2019 | Dec 31, 2019 | $7.36M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $741.32K | -69.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.23M | +10.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.95M | -58.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.10M | +9.9% |
| Q2 FY2025 | Jun 30, 2025 | $2.44M | +110.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.11M | -72.9% |
| Q4 FY2024 | Dec 31, 2024 | $4.67M | +30.0% |
| Q3 FY2024 | Sep 30, 2024 | $998.22K | -91.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.16M | -93.3% |
| Q1 FY2024 | Mar 31, 2024 | $4.08M | -85.5% |
| Q4 FY2023 | Dec 31, 2023 | $3.60M | -88.8% |
| Q3 FY2023 | Sep 30, 2023 | $11.22M | -57.2% |
| Q2 FY2023 | Jun 30, 2023 | $17.41M | -46.3% |
| Q1 FY2023 | Mar 31, 2023 | $28.24M | -19.5% |
| Q4 FY2022 | Dec 31, 2022 | $32.06M | -12.7% |
| Q3 FY2022 | Sep 30, 2022 | $26.22M | -34.6% |
| Q2 FY2022 | Jun 30, 2022 | $32.41M | +541.8% |
| Q1 FY2022 | Mar 31, 2022 | $35.09M | +411.8% |
| Q4 FY2021 | Dec 31, 2021 | $36.71M | +334.2% |
| Q3 FY2021 | Sep 30, 2021 | $40.11M | +518.8% |
| Q2 FY2021 | Jun 30, 2021 | $5.05M | +59.4% |
| Q1 FY2021 | Mar 31, 2021 | $6.86M | -6.8% |
| Q4 FY2020 | Dec 31, 2020 | $8.46M | – |
| Q3 FY2020 | Sep 30, 2020 | $6.48M | – |
| Q2 FY2020 | Jun 30, 2020 | $3.17M | – |
| Q4 FY2019 | Dec 31, 2019 | $7.36M | – |
See a number that looks wrong?